Regenerative engineering innovation in early intervention of osteoarthritis

(101227121 — RENOVATE — HORIZON-MSCA-2024-DN-01)

HORIZON TMA MSCA Doctoral Networks – Marie Skłodowska-Curie Actions (MSCA)

Osteoarthritis (OA) affects millions of people worldwide, and current treatment often fails to repair lost cartilage, with patients resorting to joint replacement. Emerging tissue-engineering developments are on the horizon, but functional long-term regeneration is an issue. Supported by the Marie Skłodowska-Curie Actions programme, the RENOVATE project aims to combine multinational, multidisciplinary research with training to develop osteochondral scaffolds to treat extensive cartilage defects. Specifically, the project will draw on patient-specific data to optimise scaffold function, mechanical properties, and biological function, and to improve 3D printing technologies for graded, multi-material structures. It will train future biomedical engineers and clinicians, bridge academic and clinical disciplines, and empower them with cutting-edge skills, advancing OA therapy and inspiring regenerative-medicine careers.

Recruitment

Below you will find detailed information on the opportunities offered within the RENOVATE Doctoral Network, including the conditions of the PhD positions, the profile and eligibility requirements for candidates, and the available doctoral vacancies. The section also outlines the application framework and the documentation required to apply.

Regenerative engineering innovation in early intervention of osteoarthritis
Privacy overview

This website uses cookies to ensure we can provide you with the best possible user experience.
The information stored in cookies is saved in your browser and performs functions such as recognizing you when you return to our website or helping our team understand which sections of the site you find most interesting and useful.